NCT05439460 - Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Phenylephrine

5 subjects will get Phenylephrine during cardiac catheterization in patient with known Pulmonary Arterial Hypertension.Dose will be 1ug/kg body weight. Pressures in the pulmonary artery will be measured before and after the drug administration.

DRUG

Epinephrine

5 subjects will get Epinephrine during cardiac catheterization in patient with known Pulmonary Arterial Hypertension.Dose will be 0.5-1ug/kg body weight. Pressures in the pulmonary artery will be measured before and after the drug administration.

DRUG

Arginine Vasopressin

5 subjects will get Arginine Vasopressin during cardiac catheterization in patient with known Pulmonary Arterial Hypertension.Dose will be 1ug/kg body weight. Pressures in the pulmonary artery will be measured before and after the drug administration.

Trial Locations (1)

94043

Cardiac Catheterization Lab,Stanford University Medical Center, Stanford

All Listed Sponsors

lead

Stanford University

OTHER